TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 5 Aug 2025, 16:26 BST

Official UK procurement notice

NP49425 Generic and Biosimilar Transition Medicines

Official notice

Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)

Framework agreement10 lotsGoodsOpen procedure
Sectors: Medical Devices & Pharma (33) Delivery: Scotland (UKM)
Framework ceiling (notional)£234,969,011total for 10 lots · framework ceiling, not attributable revenue · 1 value update
Submissions closed 24 Sept 2025awarded 18 Dec 2025
Lots 10see the lot list below
Framework period 2 yrs 8 moends 28 Feb 2027 · extension options published · starts 1 Feb 2026

What is being bought10 lots · detail below

Published requirement description

Supply of generic and biosimilar transition medicines to NHS Scotland.

CPV: Pharmaceutical products

How this framework works

From the published notice
Places
up to 50 suppliers · 42 bids on the busiest of 10 lots (0.8 per place) · 37 appointed
Framework period
2 yrs 8 mo from 1 Feb 2026

Lots and requirements (10)Procurement structure

10 lots · all with a published value · same evaluation weights on every lot
Lot #1Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)CancelledRenewal 2 yrs 8 moPublished value£99,950,577

Supply of generic cand biosimilar transition medicines to NHS Scotland.

The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants.

Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.

Contract period: 1 Feb 2026 – 28 Feb 2027 (2 yrs 8 mo)
Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-five (35) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #2Cytokine Modulators (Omalizumab)CancelledRenewal 11 moPublished value£15,643,757

Supply of cytokine modulators (omalizumab) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.

Contract period: 1 Apr 2026 – 28 Feb 2027 (11 mo)
Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-five (35) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #3Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis MedicinesCancelledRenewal 1 yr 6 moPublished value£26,183,523

Supply of gastrointestinal, endocrine, blood, and multiple sclerosis medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Contract period: 1 Feb 2026 – 31 Jul 2027 (1 yr 6 mo)
Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty (30) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #4Denosumab (Osteoporosis) and Ferric CarboxymaltoseCancelledRenewal 1 yr 6 moPublished value£27,420,432

Supply of denosumab (osteoporosis) and ferric carboxymaltose to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.

Contract period: 1 Feb 2026 – 31 Jul 2027 (1 yr 6 mo)
Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty (30) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #5ApremilastCancelledRenewal 1 yr 9 moPublished value£1,495,958

Supply of apremilast to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Contract period: 1 Feb 2026 – 31 Oct 2027 (1 yr 9 mo)
Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-seven (27) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #6Cardiovascular and Respiratory MedicinesCancelledRenewal 2 yrs 4 moPublished value£457,484

Supply of cardiovascular and respiratory medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Contract period: 1 Feb 2026 – 30 May 2028 (2 yrs 4 mo)
Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #7NintedanibCancelledRenewal 2 yrs 2 moPublished value£27,322,496

Supply of nintedanib to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Contract period: 1 Apr 2026 – 30 May 2028 (2 yrs 2 mo)
Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #8Cancer Medicines (Group 1)CancelledRenewal 1 yrPublished value£15,175,245

Supply of cancer medicines (group 1) to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Contract period: 1 Feb 2026 – 31 Jan 2027 (1 yr)
Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-six (36) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #9Cancer Medicines (Group 2)CancelledRenewal 1 yrPublished value£21,258,752

Supply of cancer medicines (group 2) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.

Contract period: 1 Feb 2026 – 31 Jan 2027 (1 yr)
Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-six (36) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #10Psychiatry and Neurology MedicinesCancelledRenewal 2 yrs 8 moPublished value£60,787

Supply of psychiatry and neurology medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

Contract period: 1 Feb 2026 – 30 Sept 2028 (2 yrs 8 mo)
Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of seventeen (17) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored · same split on all 10 lots
Quality: 5%Price: 95%
Published sub-criteria (2)
  • Supply Chain: 5%
  • price: 95%
Published award criteria (2)
  • Supply Chain: 5
  • Price: 95
Conditions of participation2
  • Suitability

    Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

  • Technical & professional ability

    (a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the start date of the Framework Agreement.

    AND

    (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.

    AND

    (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.

    AND

    (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.

    Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the…
What this means for your bid
  • Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
  • “NP49425 Generic and Biosimilar Transition Medicines” is a framework: the contest is a place on its panel, up to 50 suppliers, not a single contract.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
5 Aug 2025, 16:26 BST
Last source update
30 Mar 2026, 14:46 BST
Award evaluation window
22 Sept 2025 – …
FTS notice number
2026/S 000-029168
Classification (CPV)
Pharmaceutical products
Delivery area
Scotland (UKM)
Official registry OCID
ocds-h6vhtk-0581ea Find a Tender
Contract terms
Electronic trading
e-invoicing allowed · electronic ordering · electronic payment
Review and risk notes
Review procedure

Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:

An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.

The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.

Publisher note: The estimated values referred to in Section II.I.7 and Section V.2.4 (and within all Lots) cover both the initial duration (which is variable, depending on the Lot) and the optional extension period (which is variable, depending on the Lot) -- covering a maximum total duration of forty-eight (48) months. Details of individual product lines awarded within a specific Lot can be requested from the named person at the head of this notice. (SC Ref:827046)

How it was run

Official notice
Run through: Public Contracts Scotland · Who buys & how to bid on PCS
Supplier login requiredLanguage: EN
Access & registration note: Free single registration for Scotland; PCS-Tender (Jaggaer) for full bidding
Appointment period ends
24 Sept 2025, 12:00 BST
Submission channel
{"electronicSubmission"}
Accepted languages
en
Bid validity
90 days from the deadline
Bids opened
22 Sept 2025, 12:00 BST
Detailed submission instructions & authority contactsFrom official release

www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ↗

Timeline

15 Aug 2025 → 30 Mar 2026 · 5 dates
  1. Next notice expected
    15 Aug 2025, 00:00 BST
  2. Bids opened395 days ago
    22 Sept 2025, 12:00 BST
  3. Admission / appointment period ends393 days ago · period end, not a bid countdown
    24 Sept 2025, 12:00 BST
  4. Contract starts264 days ago
    1 Feb 2026
  5. Notice published206 days ago
    30 Mar 2026, 14:46 BST

Notice history

6 events · 5 releases on Find a Tender · since 21 Aug 2025
  1. Published value updated to £234,969,011
    21 Aug 2025, 10:55 BST
    was £131,244,104
  2. Status changed to active
    21 Aug 2025, 10:55 BST
  3. Procurement method changed
    21 Aug 2025, 10:55 BST
  4. Deadline published: 22 Sept 2025, 12:00 BST
    21 Aug 2025, 10:55 BST
  5. Deadline moved to 24 Sept 2025, 12:00 BST
    4 Sept 2025, 17:01 BST
    +2 days · was 22 Sept 2025, 12:00 BST
  6. Status changed to complete
    19 Dec 2025, 16:55 GMT
Published amendments (1 · 1 deadline change)
WhenWhatBeforeAfterShift
—DeadlineTime limit · IV.2.222 Sept 202524 Sept 2025+2 d
—Bid openingConditions for opening of tenders · IV.2.722 Sept 202524 Sept 2025+2 d
—Contract periodDuration Start · II.2.71 Apr 20261 May 2026+30 d

1) Invitation to Tender published later than expected. Adjustment to deadline to meet minimum timescale requirement. 2) Lot 7 start date changed to avoid originator marketing exclusivity infringement.

Routine re-releases (5)
  • 2025-08: 2 releases · 5 Aug 2025, 21 Aug 2025

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 37admitted to the panel · see the list ↓
Bids received 42busiest of 10 lots
Contracts signed 11latest 18 Dec 2025

11 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

  • Contract 029168-2026-NP49425-1

    Signed
    18 Dec 2025
    Value
    £64,103,740
    Period
    … – 28 Feb 2027
    Status
    active
    • Change No changes; clarification of Framework Agreement initial duration (thirty-two (32) months) and extension duration (sixteen (16) months) only. Individual Lot durations vary and information is available on request., Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee: No changes; clarification of Framework Agreement initial duration (thirty-two (32) months) and extension duration (sixteen (16) months) only. Individual Lot durations vary and information is available on request.

  • Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)

    Signed
    18 Dec 2025
    Value
    £26,539,272
    Period
    … – 28 Feb 2027
    Status
    active

  • Psychiatry and Neurology Medicines

    Signed
    18 Dec 2025
    Value
    £188,432
    Period
    … – 30 Sept 2028
    Status
    active

  • Cytokine Modulators (Omalizumab)

    Signed
    18 Dec 2025
    Value
    £9,253,091
    Period
    … – 28 Feb 2027
    Status
    active

  • Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines

    Signed
    18 Dec 2025
    Value
    £3,594,493
    Period
    … – 31 Jul 2027
    Status
    active

  • Denosumab (Osteoporosis) and Ferric Carboxymaltose

    Signed
    18 Dec 2025
    Value
    £2,254,091
    Period
    … – 31 Jul 2027
    Status
    active

  • Apremilast

    Signed
    18 Dec 2025
    Value
    £663,520
    Period
    … – 31 Oct 2027
    Status
    active

  • Cardiovascular and Respiratory Medicines

    Signed
    18 Dec 2025
    Value
    £78,009
    Period
    … – 30 May 2028
    Status
    active

  • Nintedanib

    Signed
    18 Dec 2025
    Value
    £1,400,387
    Period
    … – 30 May 2028
    Status
    active

  • Cancer Medicines (Group 1)

    Signed
    18 Dec 2025
    Value
    £1,925,364
    Period
    … – 31 Jan 2027
    Status
    active

  • Cancer Medicines (Group 2)

    Signed
    18 Dec 2025
    Value
    £18,207,081
    Period
    … – 31 Jan 2027
    Status
    active

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)42bids · 42 electronic · 42 from abroad0——
2 · Cytokine Modulators (Omalizumab)42bids · 42 electronic · 42 from abroad0——
3 · Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines42bids · 42 electronic · 42 from abroad0——
4 · Denosumab (Osteoporosis) and Ferric Carboxymaltose42bids · 42 electronic · 42 from abroad0——
5 · Apremilast42bids · 42 electronic · 42 from abroad0——
6 · Cardiovascular and Respiratory Medicines42bids · 42 electronic · 42 from abroad0——
7 · Nintedanib42bids · 42 electronic · 42 from abroad0——
8 · Cancer Medicines (Group 1)42bids · 42 electronic · 42 from abroad0——
9 · Cancer Medicines (Group 2)42bids · 42 electronic · 42 from abroad0——
10 · Psychiatry and Neurology Medicines42bids · 42 electronic · 42 from abroad0——

Contracting authority & participating public bodies

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contracting authorityNHS & healthcareBody governed by public lawHealth 1 South Gyle Crescent, Edinburgh, Scotland, EH12 9EBContact name, email, phone Published organisation website ↗

Framework contractors & participating bidders

42 commercial parties on the notice
  • AOP Orphan LtdFramework contractor Halkin Mainframe, , 24 Eversholt Street, London, UK, NW1 1AD
  • AOP Orphan LtdFramework contractor Colmore Plaza, 20 Colmore Circus Queensway, Birmingham, UK, B4 6ATContact phone
  • Accord Healthcare LtdFramework contractor Sage House, 319 Piner Road, North Harrow, UK, HA1 4HF
  • Amarox LimitedFramework contractor 14 Lyon Road, Congress house, 3rd Floor, Harrow, UK, HA1 2ENContact phone
  • Amgen LtdFramework contractor 216 Cambridge Science Park, Milton Road, Cambridge, UK, CB4 0WAContact phone
  • Biocon Pharma UK LtdFramework contractor 16 Great Queen Street, Covent Garden, London, London, WC2B 5AHContact phone
  • Brown and BurkFramework contractor 5 Marryat close, Hounslow, West London, UK, TW4 5DQ
  • CST Pharma LtdFramework contractor Unit 5-7, Westgate Park Industrial Estate, Tintagel Way, Walsall, UK, WS9 8ER
  • Celix Pharma Ltd.Framework contractor 12 Constance Street, International House, London, London, E16 2DQContact phone
  • Celltrion Healthcare United Kingdom LimitedFramework contractor 1-7 The Switch, Slough, UK, SL1 1QPContact phone
Show 32 more suppliers
  • Chiesi LimitedFramework contractor Chiesi Limited, 333 Styal Road, Manchester, UK, M22 5LGContact phone
  • Chiesi LtdFramework contractor Manchester Green, 333 Styal Road, Manchester, UK, M22 5LG
  • Dr Falk Pharma UK LtdFramework contractor Unit K Bourne End Business Park, Cores End Road, Bourne End, Bucks, UK, SL8 5ASContact phone
  • Dr Reddy's Laboratories (UK) LtdFramework contractor 410, Cambridge Science Park,, Milton Road, Milton,, Cambridge, UK, CB4 0PEContact phone
  • Ferring Pharmaceuticals LimitedFramework contractor Drayton Hall, Church Road, West Drayton, UK, UB7 7PS
  • Fresenius KabiFramework contractor Cestrian Court, Runcorn, UK, WA7 1NT
  • Fresenius Kabi LtdFramework contractor Cestrian Court, Eastgate Way,, Manor Park, Runcorn, Cheshire, Runcorn, UK, WA7 1NT
  • Gedeon Richter UK LtdFramework contractor 127 Shirland Road, London, UK, W9 2EPContact phone
  • Glenmark Pharmaceuticals Europe LtdFramework contractor Building 2, Croxley Green Business Park, Watford, UK, WD18 8YAContact phone
  • Janssen-Cilag LtdFramework contractor 50-100 Holmers Farm Way, High Wycombe, South East, HP12 4DPContact phone
  • Lupin Healthcare UK LtdFramework contractor The Urban Building, 3-8 Albert Street, Slough, South East, SL1 2BEContact phone
  • MSN LabsFramework contractor Works Road, LETCHWORTH GARDEN CITY, UK, SG6 1GJContact phone
  • Mercury Pharma GroupFramework contractor No.1 Croydon, 12-16 Addiscombe Road, Croydon, UK, CR0 0XT
  • Mercury Pharmaceuticals LimitedFramework contractor Dashwood House, , 2nd Floor, 69 Old Broad Street,, London, United Kingdom., London, EC2M 1QSContact phone
  • Perennial Pharma LtdFramework contractor Titan Court, 2nd Floor, 3 Bishop Square, Hatfield, UK, AL10 9NA
  • Perennial Pharma LtdFramework contractor Titan Court, Second floor 3 Bishop Square, Hatfield, UK, AL10 9NAContact phone
  • PfizerFramework contractor Pfizer Ltd, Walton Oaks, Dorking Road, Tadworth, UK, KT20 7NSContact phone
  • Roche Products LtdFramework contractor 6 Falcon Way, Shire Park, Welwyn Garden City, UK, AL7 1TWContact phone
  • SERB SAFramework contractor AVENUE LOUISE 480., BRUSSELS, BE, 1050Contact phone
  • STADA UK - Thornton & RossFramework contractor Linthwaite, Huddersfield, UK, HD7 5JNContact phone
  • Samsung Bioepis LtdFramework contractor 5th Floor , Profile West, 950 Great West Road,, Brentford, UK, TW8 9ESContact phone
  • SandozFramework contractor Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, UK, GU15 3YLContact phone
  • Takeda UK LimitedFramework contractor 1 Kingdom Street, London, Scotland, W2 6BDContact phone
  • Teva UK LtdFramework contractor Ridings Point, Whistler Drive, Glasshoughton, Castleford, UK, WF10 5HXContact phone
  • Theramex HQ UK LtdFramework contractor Sloane Square House, 1 Holbien Place, London, UK, SW1W 8NS
  • Viatris UK Healthcare LtdFramework contractor Building 4, Trident Place, Mosquito Way, Hatfield, East of England, AL10 9ULContact phone
  • Vifor Pharma UK LimitedFramework contractor Point - Level 3, 29 Market Street, Maidenhead, South East, SL6 8AAContact phone
  • Wockhardt UK LimitedFramework contractor Ash Road North, Wrexham Ind Estate, Wrexham, Wrexham, UK, LL13 9UFContact phone
  • Zentiva Pharma UK LtdFramework contractor 12 New Fetter Lane, london, UK, EC4A 1JP
  • Zentiva UKFramework contractor First Floor, United Kingdom, Andrews House College Road, Guildford England, UK, GU1 4QBContact phone
  • Zydus Pharmaceuticals UK LtdFramework contractor First Floor, Templeback, 10, Temple back, Bristol, South West, BS1 6FLContact phone
  • Zydus Pharmaceuticals UK LtdFramework contractor ZPUK Office, Sandretto Building Cavalry Hill Industrial Park, Weedon, East Midlands, NN7 4PP

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.